In the present study PPP treatment resulted in prominent CDK1 activation with increased levels of Cyclin B1 protein and mRNA, increased Cyclin B1 in complex with CDK1, and CDK1Thr161 phosphorylation in cancer cell lines or tumors. The gene discussed is CCNB1; the disease is cancer.